PerkinElmer has agreed to acquire Caliper Life Sciences, a company providing imaging and detection solutions to the life sciences research, diagnostics and environmental markets, for US$10.50 per share or a total cash purchase price of approximately US$600 M. The transaction has been approved by the Boards of Directors of both companies and is expected to close in the fourth quarter of 2011. The acquisition will expand PerkinElmer’s product portfolio with the addition of complementary offerings with applications in fields such as genomics, translational medicine research and biotherapeutics development.